Equitec Proprietary Markets’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Equitec Proprietary Markets’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.61K	Hold	1,900	–	–	﹤0.01%	78
2026 Q1	$1.9K	Hold	1,900	–	–	﹤0.01%	66
2025 Q4	$646	Hold	1,900	–	–	﹤0.01%	77
2025 Q3	$656	Hold	1,900	–	–	﹤0.01%	72
2025 Q2	$418	Hold	1,900	–	–	﹤0.01%	62
2025 Q1	$451	Hold	1,900	–	–	﹤0.01%	60
2024 Q4	$399	Hold	1,900	–	–	﹤0.01%	53
2024 Q3	$361	Hold	1,900	–	–	﹤0.01%	62
2024 Q2	$385	Hold	1,900	–	–	﹤0.01%	65
2024 Q1	$475	Hold	1,900	–	–	﹤0.01%	79
2023 Q4	$366	Sell	1,900 -9,676	-84%	-$2.34K	﹤0.01%	93
2023 Q3	$2.92K	Sell	11,576 -4,624	-29%	-$1.49K	﹤0.01%	96
2023 Q2	$6.4K	Sell	16,200 -10,700	-40%	-$3.27K	﹤0.01%	79
2023 Q1	$7.53K	Sell	26,900 -10,000	-27%	-$3.79K	﹤0.01%	94
2022 Q4	$9.23K	Hold	36,900	–	–	﹤0.01%	135
2022 Q3	$16K	Hold	36,900	–	–	﹤0.01%	169
2022 Q2	$18K	Sell	36,900 -200	-0.5%	-$111	0.01%	167
2022 Q1	$23K	Buy	+37,100	New	+$20.2K	0.01%	139

Other funds holding DRTSW

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Equitec Proprietary Markets's DRTSW Position: Q2 2026 in Review

Equitec Proprietary Markets held its Alpha Tau Medical Warrant (DRTSW) position steady in Q2 2026 at 1,900 shares worth $5.61K. The position accounts for ﹤0.01% of the portfolio, ranked #78.

Equitec Proprietary Markets first reported a position in DRTSW in Q1 2022 and has held it in 18 quarters since. The position peaked at $23K in Q1 2022. 21 funds tracked by Wall St. Rank hold DRTSW as of Q2 2026.

Equitec Proprietary Markets held 1,900 shares of Alpha Tau Medical Warrant worth $5.61K as of Q2 2026.
Equitec Proprietary Markets left its Alpha Tau Medical Warrant share count unchanged in Q2 2026.
Alpha Tau Medical Warrant made up ﹤0.01% of Equitec Proprietary Markets's portfolio in Q2 2026, its #78 holding.
Equitec Proprietary Markets first reported a position in Alpha Tau Medical Warrant in Q1 2022 and has held it in 18 quarters since.
Equitec Proprietary Markets's Alpha Tau Medical Warrant position peaked at $23K in Q1 2022.
21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2026.

Based on Equitec Proprietary Markets's 13F filing for Q2 2026, filed 20 Jul 2026.